|
|
|
08.07.25 - 05:36
|
Argent BioPharma to Supply Cannabinoid Treatment for Drug-Resistant Epilepsy in Slovenia (Small Caps)
|
|
|
Argent BioPharma (ASX: RGT) has commenced the supply of a cannabinoid-based active pharmaceutical ingredient (API) to treat refractory (or drug-resistant) epilepsy patients at Slovenia's largest hospital. The API will be transitioned to routine use at the paediatric clinic within University Medical Centre Ljubljana (UMCL) following a successful pilot program, enabling neurologists to dispense recommended, protocol-aligned […]
The post Argent BioPharma to Supply Cannabinoid Treatment for Drug-Resistant Epilepsy in Slovenia appeared first on Small Caps....
|
|
|
24.04.25 - 01:01
|
Argent BioPharma Enters Germany - Europe′s Largest Market (PR Newswire)
|
|
|
Strategic Expansion Paired with Over $1M in Annual Cost Savings from Operational Restructuring PERTH, Australia, April 23, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company specializing in neuroimmune therapies, is pleased to......
|
|
|
|
|
03.04.25 - 06:36
|
Argent BioPharma gains approval for prescription sales of CannEpil epilepsy treatment in Germany (Small Caps)
|
|
|
Argent BioPharma's (ASX: RGT) flagship CannEpil cannabinoid-based therapy for the treatment of refractory (or drug-resistant) epilepsy has been approved for prescription in Germany under a special access scheme. The approval means that doctors can now prescribe the drug to eligible patients, who may also qualify for health insurance coverage depending on the doctor's recommendation and […]
The post Argent BioPharma gains approval for prescription sales of CannEpil epilepsy treatment in Germany appeared first on Small Caps....
|
|
|
16.03.25 - 23:03
|
Argent BioPharma Expands Pipeline with Promising Drug CimetrA® (PR Newswire)
|
|
|
PERTH, Australia, March 16, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune......
|
|
|
05.03.25 - 03:01
|
Argent BioPharma signs manufacturing partnership with ECCPharm for emerging cannabinoid therapies (Small Caps)
|
|
|
Argent BioPharma (ASX: RGT) has confirmed that pharmaceutical manufacturer ECCPharm will take on full production and release responsibilities for Argent's emerging cannabinoid therapies under a strategic partnership between the two companies. The agreement will ensure the CannEpil and CogniCann treatments are available under early patient access programs in key European countries including Ireland, the UK […]
The post Argent BioPharma signs manufacturing partnership with ECCPharm for emerging cannabinoid therapies appeared first on Small Caps....
|
|
|
07.01.25 - 12:27
|
Argent BioPharma Ltd. Raised US$4,500,000 (PR Newswire)
|
|
|
PERTH, Australia, Jan. 7, 2025 /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation......
|
|
|
07.01.25 - 09:30
|
XFRA : H5O0: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
ARGENT BIOPHARMA LTD. H5O0 AU0000326647
AB/FROM ONWARDS 07.01.2025 09:23 CET...
|
|
|
06.01.25 - 21:03
|
Argent BioPharma Ltd. Placing to Raise US$4,500,000 (PR Newswire)
|
|
|
PERTH, Australia, Jan. 6, 2025 /PRNewswire/ -- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation......
|
|
|
03.01.25 - 08:02
|
XFRA : H5O0: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
ARGENT BIOPHARMA LTD. H5O0 AU0000326647 BAW/UFN...
|
|
|
|
|
|
|
12.09.24 - 09:39
|
XFRA : H5O0: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
ARGENT BIOPHARMA LTD. H5O0 AU0000326647
AB/FROM ONWARDS 12.09.2024 09:36 CET...
|
|
|
13.08.24 - 07:57
|
XFRA : H5O0: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
ARGENT BIOPHARMA LTD. H5O0 AU0000326647 BAW/UFN...
|
|
|
|
|
18.07.24 - 16:20
|
XFRA : H5O0: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
ARGENT BIOPHARMA LTD. H5O0 AU0000326647
AB/FROM ONWARDS 18.07.2024 16:14 CET...
|
|
|
12.07.24 - 08:16
|
XFRA : H5O0: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
ARGENT BIOPHARMA LTD. H5O0 AU0000326647 BAW/UFN...
|
|
|
|
|
08.07.24 - 13:49
|
XFRA : H5O0: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
ARGENT BIOPHARMA LTD. H5O0 AU0000326647
AB/FROM ONWARDS 08.07.2024 13:14 CET...
|
|
|
28.06.24 - 09:21
|
XFRA : H5O0: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
ARGENT BIOPHARMA LTD. H5O0 AU0000326647 BAW/UFN...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
